ADHD in adults
ADHD is not just a childhood condition. Many adults live with persistent difficulty focusing, staying organized, following through, or managing impulses, often without ever having been evaluated.
Adult ADHD can look different from the childhood picture most people imagine. It often shows up as chronic disorganization, losing track of time, starting projects and struggling to finish, restlessness, or speaking and acting on impulse. Many adults reach us after years of wondering why everyday life feels harder than it seems to be for everyone else.
A careful evaluation looks at your full history, not just a checklist. ADHD shares features with anxiety, depression, and sleep problems, so getting the diagnosis right matters. Stimulant medications like Adderall work by increasing dopamine and norepinephrine activity in the brain circuits that handle focus, planning, and impulse control. In plain terms, they strengthen the brain's own braking and steering systems, which is why everyday tasks feel less effortful on them. Non stimulant options act on similar pathways in a different way. Treatment is individualized and any plan is made together with you.
Research and further reading
A few key papers behind how this condition is understood and treated today. Links open the abstract on PubMed, a free public database from the U.S. National Library of Medicine.
-
Cortese et al. · The Lancet Psychiatry · 2018
Across 133 trials, several medications reduced adult ADHD symptoms in the short term, with amphetamines showing the strongest average efficacy in adults, although tolerability and individual response still matter.
-
Clinical practice: Adult attention deficit hyperactivity disorder
Volkow et al. · The New England Journal of Medicine · 2013
Stimulants and atomoxetine improve adult ADHD symptoms in short term studies, while evidence about long term benefits and risks remains more limited.
-
Weisler et al. · CNS Spectrums · 2006
In 255 adults with ADHD, extended release mixed amphetamine salts reduced symptoms more than placebo within the first week, with benefits lasting about 12 hours.
-
Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults
Castells et al. · Cochrane Database of Systematic Reviews · 2011
Across seven trials with 1,091 adults, amphetamines including mixed amphetamine salts reduced ADHD symptoms, though short study lengths and high dropout limit certainty.
-
Nasser et al. · Journal of Clinical Psychopharmacology · 2021
In 310 adolescents studied over 6 weeks, both tested doses of viloxazine ER improved ADHD symptom scores and overall clinical impression more than placebo. Sleepiness, headache, reduced appetite, nausea, and fatigue were the most common side effects, and fewer than 5 percent stopped treatment because of side effects.
-
Atomoxetine in adults with ADHD: two randomized, placebo controlled studies
Michelson et al. · Biological Psychiatry · 2003
Across two 10 week trials with 536 adults, atomoxetine reduced both inattentive and hyperactive impulsive symptoms more than placebo. Fewer than 10 percent of participants taking atomoxetine stopped because of side effects in either trial.
-
Ostinelli et al. · The Lancet Psychiatry · 2025
Across 113 trials in adults, stimulants and atomoxetine were the only interventions with clear evidence of reducing core ADHD symptoms in the short term. Atomoxetine had higher dropout rates than placebo, and evidence beyond 12 weeks was sparse.
-
Nasser et al. · CNS Drugs · 2022
In 374 adults with ADHD, viloxazine ER 200 to 600 mg per day improved ADHD symptom scores more than placebo over 6 weeks, with effects seen by week 2. Insomnia, fatigue, and nausea were the most common side effects.
-
Pharmacological interventions for ADHD: a systematic review and dose effect network meta analysis
Nourredine et al. · Lancet Psychiatry · 2026
Across 113 randomized trials of ADHD medications in people age five and older, the study mapped how efficacy and tolerability change with dose, finding that increasing the dose helped symptoms up to a point before the extra benefit leveled off and side effect related dropouts rose with higher doses.
-
Rutledge-Jukes et al. · Cureus · 2024
In a meta analysis of randomized trials, the stimulant lisdexamfetamine eased both inattentive and hyperactive impulsive ADHD symptoms more than placebo, and the safety profile looked similar across the doses studied.
Think this might be you?
Reach out and tell us what you're experiencing. We'll help you figure out the right starting point, no pressure.
Book a Consultation